These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 991841)

  • 41. [Serum content of somatotropic hormone and its autoantibodies in healthy children and those with a growth disorder].
    Kurbanov TG; Ianshina MN
    Probl Endokrinol (Mosk); 1974; 20(1):33-6. PubMed ID: 4849696
    [No Abstract]   [Full Text] [Related]  

  • 42. [Possible influence on basal growth hormone secretion by treatment with anabolic drug].
    Girard J; Vest M
    Schweiz Med Wochenschr; 1969 Jul; 99(31):1126-7. PubMed ID: 5406982
    [No Abstract]   [Full Text] [Related]  

  • 43. Pyridostigmine potentiates L-dopa- but not arginine- and galanin-induced growth hormone secretion in children.
    Ghigo E; Bellone J; Imperiale E; Arvat E; Mazza E; Valetto MR; Boffano GM; Cappa M; Loche S; De Sanctis C
    Neuroendocrinology; 1990 Jul; 52(1):42-5. PubMed ID: 1697660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [HGH response to dihydroxyphenylalanine (L-dopa) (author's transl)].
    Del Valle Núñez CJ; García Guerrero M; García De Pesquera F; Pérez Bryan J
    An Esp Pediatr; 1976; 9(2):174-9. PubMed ID: 937869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Growth hormone response in very short children.
    Palayew K; Crock P; Pianosi P; Coates A; Weitzner G; Schiffrin A
    Clin Invest Med; 1991 Aug; 14(4):331-7. PubMed ID: 1782731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Radioimmunological determination of growth hormone following stimulation with insulin and arginine in 168 subjects with growth disorders].
    de Toni E; Aicardi G
    Minerva Pediatr; 1976 May; 28(17):1027-34. PubMed ID: 1012170
    [No Abstract]   [Full Text] [Related]  

  • 47. Growth hormone studies before and during catch-up growth in a child with emotional deprivation and short stature.
    Powell GF; Hopwood NJ; Barratt ES
    J Clin Endocrinol Metab; 1973 Nov; 37(5):674-9. PubMed ID: 4356135
    [No Abstract]   [Full Text] [Related]  

  • 48. [Use of the levodopa test in the study of children with growth disorders].
    De Sanctis V; Bagni B; Ranalli F; Vullo C; Malavasi F
    Minerva Pediatr; 1976 May; 28(17):1042-6. PubMed ID: 1012172
    [No Abstract]   [Full Text] [Related]  

  • 49. [Growth hormone secretion in growth retarded children and adolescents].
    Rohrberg R; Ulrich FE; Schneyer U; Seige K
    Z Gesamte Inn Med; 1981 Mar; 36(5):168-72. PubMed ID: 7018101
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relative usefulness of three growth hormone stimulation screening tests.
    Fass B; Lippe BM; Kaplan SA
    Am J Dis Child; 1979 Sep; 133(9):931-3. PubMed ID: 474543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine.
    Mims RB; Scott CL; Modebe O; Bethune JE
    J Clin Endocrinol Metab; 1975 Feb; 40(2):256-9. PubMed ID: 1117978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Test with levodopa in the evaluation of somatotropin secretion].
    Stoppoloni G; Prisco F; Palmieri A
    Minerva Pediatr; 1976 May; 28(17):1058-64. PubMed ID: 1012176
    [No Abstract]   [Full Text] [Related]  

  • 53. [Attempt at potentiation of the action of L-dopa on the secretion of growth hormone by benserazide, disulfiram and propranolol].
    Rochiccioli P; Enjaume P; Dutau G; Ribot C; Augier D
    Arch Fr Pediatr; 1976 Jan; 33(1):55-66. PubMed ID: 985031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth hormone response to intramuscular glucagon.
    Wieland RG; Hallberg MC; Zorn EM
    J Clin Endocrinol Metab; 1973 Aug; 37(2):329-30. PubMed ID: 4720076
    [No Abstract]   [Full Text] [Related]  

  • 55. Blindness impairs plasma growth hormone response to L-dopa but not to arginine.
    Bellastella A; Parlato F; Sinisi AA
    J Clin Endocrinol Metab; 1990 Apr; 70(4):856-8. PubMed ID: 2318945
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Growth hormone secretion following metopirone administration].
    Szybiński Z; Sieradzki J; Korzeniowska D
    Pol Arch Med Wewn; 1975 Jun; 53(6):597-604. PubMed ID: 1138250
    [No Abstract]   [Full Text] [Related]  

  • 57. Growth hormone refractory interval to levodopa stimulation.
    Parker KM; Eddy RL
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1188-91. PubMed ID: 932184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. L-Dopa stimulated growth hormone release in the blind.
    Bellastella A; Colucci CF; D'Alessandro B; Lo Cicero M
    J Clin Endocrinol Metab; 1977 Jan; 44(1):194-5. PubMed ID: 833257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular forms of human growth hormone secreted in vivo: nonspecificity of secretory stimuli.
    Baumann G; Stolar MW
    J Clin Endocrinol Metab; 1986 Apr; 62(4):789-90. PubMed ID: 3081572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Growth hormone in exercise: comparison of physiological and pharmacological stimuli.
    Sutton J; Lazarus L
    J Appl Physiol; 1976 Oct; 41(4):523-7. PubMed ID: 985395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.